Overprescription of short‐acting β2‐agonists among patients with asthma in Saudi Arabia: Results from the SABINA III cohort study

Overprescription of short‐acting β2‐agonists among patients with asthma in Saudi Arabia: Results from the SABINA III cohort study

Abstract Despite near‐universal health care and timely updates to treatment guidelines in Saudi Arabia, asthma control remains suboptimal, warranting deeper exploration of its management practices. This study describes asthma characteristics and prescription patterns of short‐acting β2‐agonists (SAB...

Full description

Bibliographic Details
Main Authors: Hamdan Al‐Jahdali, Siraj Wali, Amr S. Albanna, Abeer Al Harbi, Riyad Allehebi, Abdulmajed Arwadi, Tarek Dahan, Mohamed Fattouh, Ezzat Hamza, Maarten Beekman
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:The Clinical Respiratory Journal
Subjects:
nondrugs
prescription
asthma
bronchodilator agents
Saudi Arabia
Online Access:https://doi.org/10.1111/crj.13553

Internet

https://doi.org/10.1111/crj.13553

Similar Items